Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RNF34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TNPO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUCLG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00958 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RGS11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC441204 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBXN11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSTO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STARD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ONECUT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on